National Pension Service’s United Therapeutics UTHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$16.7M Sell
30,885
-2,208
-7% -$1.24M 0.01% 407
2026
Q1
$19.6M Sell
33,093
-14,800
-31% -$7.37M 0.01% 406
2025
Q4
$23.3M Buy
47,893
+7,249
+18% +$3.38M 0.02% 405
2025
Q3
$17M Buy
40,644
+9,202
+29% +$3.09M 0.01% 413
2025
Q2
$9.03M Hold
31,442
0.01% 423
2025
Q1
$9.69M Hold
31,442
0.01% 423
2024
Q4
$11.1M Sell
31,442
-82,300
-72% -$30.3M 0.01% 490
2024
Q3
$40.8M Buy
113,742
+31,442
+38% +$10.6M 0.04% 356
2024
Q2
$26.2M Buy
+82,300
New +$21.8M 0.03% 461

Other funds holding UTHR

National Pension Service's UTHR Position: Q2 2026 in Review

National Pension Service reduced its United Therapeutics (UTHR) stake by 6.7% in Q2 2026, selling an estimated $1.24M and leaving 30,885 shares worth $16.7M. The position accounts for 0.01% of the portfolio, ranked #407.

National Pension Service first reported a position in UTHR in Q2 2024 and has held it in 9 quarters since. The position peaked at $40.8M in Q3 2024. 651 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • National Pension Service held 30,885 shares of United Therapeutics worth $16.7M as of Q2 2026.
  • National Pension Service sold 2,208 United Therapeutics shares in Q2 2026, an estimated $1.24M.
  • United Therapeutics made up 0.01% of National Pension Service's portfolio in Q2 2026, its #407 holding.
  • National Pension Service first reported a position in United Therapeutics in Q2 2024 and has held it in 9 quarters since.
  • National Pension Service's United Therapeutics position peaked at $40.8M in Q3 2024.
  • 651 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on National Pension Service's 13F filing for Q2 2026, filed 13 Aug 2026.